Concepedia

Pembrolizumab and concurrent hypo-fractionated radiotherapy for advanced non-resectable cutaneous squamous cell carcinoma

Justine Lavaud, Astrid Blom, Christine Longvert, Magali Fort, Elisa Funck‐Brentano, Philippe Saïag

European Journal of Dermatology · 2019 · 20 citations · 14 references

DOIFull text

Open access

Abstract

There appears to be a place for pembrolizumab as first-line treatment for unresectable or advanced cSCC. Further studies are needed to evaluate concomitant radiotherapy with anti-PD1 antibodies.

References

14

World Medical Association Declaration of Helsinki Ethical Principles for Medical Research Involving Human Subjects

Christiane, Druml, Wolzt et al. · 中国结合医学杂志：英文版 · 2001 · 3.4K citations

, , +10

PD-1 Blockade with Cemiplimab in Advanced Cutaneous Squamous-Cell Carcinoma

Michael R. Migden, Danny Rischin, Chrysalyne D. Schmults et al. · New England Journal of Medicine · 2018 · 1.3K citations · Full text

Stereotactic Radiation Therapy Augments Antigen-Specific PD-1–Mediated Antitumor Immune Responses via Cross-Presentation of Tumor Antigen

Andrew B. Sharabi, Christopher J. Nirschl, Christina M. Kochel et al. · Cancer Immunology Research · 2014 · 634 citations · Full text

Mutational Landscape of Aggressive Cutaneous Squamous Cell Carcinoma

Curtis R. Pickering, Jane H. Zhou, J. Jack Lee et al. · Clinical Cancer Research · 2014 · 594 citations · Full text

Phase II study of single-agent panitumumab in patients with incurable cutaneous squamous cell carcinoma

Matthew Foote, Margaret McGrath, Alexander Guminski et al. · Annals of Oncology · 2014 · 159 citations · Full text

, , +8